TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
ELDN

Eledon Pharmaceuticals Inc

Healthcare · Biotechnology

2.70$ +2.7% vs. previous close Closing price · As of: Sep 21, 2026

Statements

Cash Flow

Eledon Pharmaceuticals Inc (ELDN) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -62 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Cash Flow ELDN
Line item 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
-9.3 -15 -21 -41 -37 -15 -12 -14 -15 -29 -28 -40 -47 -62
0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.2 0.2 0.2 0.4 0.4 0.4 0.3
0.2 0.2 2.1 2.9 3.0 0.6 1.5 1.3 3.2 7.9 8.2 6.5 13 10
0.7 0.6 1.5 3.2 7.6 5.6
0.1 0.0 0.2 1.0 -2.1 -2.5 0.6 -1.2 -0.2 -0.2 2.4 -4.9 8.7 7.7
0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
0.0 -0.1 -0.2 -41 36 23 11 11 11 -70 11
0.0
0.0
2.9
19 36 95 0.5 0.0 7.9 7.6 9.7 110 -0.4 33 33 134 54
9.4 20 74 -81 -0.8 16 -4.3 -4.2 105 -29 -28 -52 16 2.3
-9.3 -15 -21 -42 -37 -15 -12 -14 -15 -29 -28 -40 -47 -62

Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?